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The p55TNFR-IKK2-Ripk3 axis orchestrates
arthritis by regulating death and inﬂammatory
pathways in synovial ﬁbroblasts
Marietta Armaka 1, Caroline Ospelt2, Manolis Pasparakis 3 & George Kollias1,4
NFκB activation and regulated cell death are important in tissue homeostasis, inﬂammation
and pathogenesis. Here we show the role of the p55TNFR–IKK2l–Ripk3 axis in the regulation
of synovial ﬁbroblast homeostasis and pathogenesis in TNF-mediated mouse models of
arthritis. Mesenchymal-speciﬁc p55TNFR triggering is indispensable for arthritis in acute and
chronic TNF-dependent models. IKK2 in joint mesenchymal cells is necessary for the
development of cartilage destruction and bone erosion; however, in its absence synovitis
still develops. IKK2 deletion affects arthritic and antiapoptotic gene expression leading
to hypersensitization of synovial ﬁbroblasts to TNF/Ripk1-mediated death via district
mechanisms, depending on acute or chronic TNF signals. Moreover, Ripk3 is dispensable for
TNF-mediated arthritis, yet it is required for synovitis in mice with mesenchymal-speciﬁc
IKK2 deletion. These results demonstrate that p55TNFR–IKK2–Ripk3 signalling orchestrates
arthritogenic and death responses in synovial ﬁbroblasts, suggesting that therapeutic
manipulation of this pathway in arthritis may require combinatorial blockade of both IKK2 and
Ripk3 signals.
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Rheumatoid arthritis (RA) is an inﬂammatory disease thatprimarily affects the synovial joints, especially the ﬁngers,wrists, feet, and ankles, resulting in painful deformities and
immobility. RA has now been associated with multi-disease syn-
dromes and comorbidities that affect bone and lipid metabolism,
the cardiovascular, gastrointestinal and respiratory systems, and
increased cancer susceptibility1. The socioeconomic burden of
rheumatic diseases is thus ampliﬁed more than once thought.
Regardless of the therapeutic advances provided by effective new
drugs, absolute remission of disease has not been achieved. Further
investigation of the aetiopathogenesis of RA is required.
Current understanding of RA pathogenesis is focused mainly
on inﬂammation in the joints, which is maintained by the
deregulated production of inﬂammatory mediators by immune
and mesenchymal cell types that are fueled mainly by tumour
necrosis factor (TNF)2,3. Functional genetic analyses in TNF-
overexpressing mice (hTNFtg4 and TNFΔARE45) highlight the
fundamental role of synovial ﬁbroblasts (SF) and p55TNFR in
mediating arthritogenesis, demonstrating that TNF/p55TNFR
signalling in SFs is sufﬁcient to orchestrate proliferation,
inﬂammation, and tissue destruction in these models6. In prin-
ciple, p55TNFR signalling is driven by complex I and II, which
consist of Tradd/Ripk1/Traf2/cIAP1 (I) and FADD/caspase-8/
Ripk1 (IIa) or Ripk1/Ripk3/Mlkl (IIb). These complexes lead to
survival and inﬂammatory signalling (such as nuclear factor κB
(NFκB), as well as death pathways that are reliant on the avail-
ability of NFκB and caspases (reviewed in ref. 7).
Aside from apoptosis, necroptosis is another form of pro-
grammed cell death controlled by the p55TNFR pathway upon
the suppression of both NFκB and caspase signalling and is
dependent on the kinase activity of Ripk1 and the interaction of
Ripk1/Ripk3/Mlkl (reviewed in ref. 8). However, there are
instances of TNF-induced necroptotic death happening in the
presence of caspase machinery such as the case of L929 ﬁbro-
sarcoma cell line9. Some other studies challenge the idea that
NFκB/caspase inhibition is required for activation of
Ripk1/Ripk3/Mlkl signalling and suggest that necroptosis induc-
tion is dependent on both the stimuli and the cell context. For
example, Toll-like receptors (TLR) are equally effective in driving
Ripk1/3-dependent and Mlkl-dependent necroptosis with differ-
ent molecular prerequisites10–13; the kinase activity of Ripk1 is
required for both p55TNFR-induced or TLR-induced necroptosis
in macrophages12,14,15, but this activity is dispensable for TLR-
induced necroptosis in endothelial cells or ﬁbroblasts12.
Given the essential role of the NFκB pathway in the tran-
scription of regulators of inﬂammatory and death responses and
the identiﬁcation of several risk loci for NFκB regulators in
patients with RA16–18, many approaches to NFκB inhibition have
been used to understand the proinﬂammatory function of NFκB
in vivo and ex vivo. Several studies have demonstrated the effect
of NFκB inhibition in the activation of RA-SFs ex vivo19–23, and
preclinical therapeutic schemes including small molecule target-
ing of IKK2 or virus-based vectors expressing inhibitors of NFκB
activation have been tested in RA models; therapeutic effects have
been shown to mainly affect immune cell activation24–28. How-
ever, the potential induction of cell death resulting from NFκB
inhibition and its contribution to arthritis is less studied28.
Further understanding of the function of NFκB and SF death
pathways in chronic inﬂammatory arthritis is necessary.
Here we dissect the requirement for mesenchymal p55TNFR
and IKK2/Ripk3 in models of acute and chronic TNF-mediated
arthritis and investigate their function in arthritic SFs. The
mechanism underlying amelioration of disease in the absence of
mesenchymal-speciﬁc IKK2 signals involves irregularities in gene
expression affecting destructive properties of SFs and differential
sensitization of SFs to Ripk1/Ripk3-mediated programmed cell
death pathways depending on the chronicity of arthritogenic TNF
signals. Our results suggest that complete amelioration of chronic
inﬂammation in arthritic diseases might require a combination of
Ripk3 inhibition with mesenchymal targeting of IKK2-mediated
signals.
Results
Mesenchymal p55TNFR is required for TNF-mediated arthri-
tis. We have previously shown in TNF-driven models of arthritis
that mesenchymal-speciﬁc TNF/p55TNFR signalling is sufﬁcient
to induce the development of full-blown pathology6. To address
whether mesenchymal-speciﬁc p55TNFR signalling is also
required for the development of arthritis, we crossed p55TNFR
conditional knockout (KO) mice29 with Col6a1-Cre mice6 in
order to generate animals which lack mesenchymal p55TNFR in
their SFs (p55TNFRMs-KO) (Supplementary Figure 1A).
p55TNFRMs-KO animals were crossed into the hTNFtg back-
ground and development of disease was monitored. We observed
that the hTNFtg p55TNFR-sufﬁcient animals developed full
disease at 10 weeks of age, while the hTNFtg p55TNFRMs-KO
animals remained completely healthy (Fig. 1a). Interestingly,
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Fig. 1Mesenchymal p55TNFR signals are necessary for the development of TNF-mediated arthritis. a Representative histological images of haematoxylin &
eosin (H&E)-stained ankle joint sections of hTNFtg p55TNFRf/f (n= 5, age: week 5; n= 8, age: week 10) and hTNFtg p55TNFRMs-KO mice (n= 8, age: weeks 5
and 10). b Representative histological images of H&E-stained ankle joint sections of p55TNFRf/f and p55TNFRMs-KO mice subjected to CAIA at the peak of
disease (Day 8). c Representative scoring of clinical manifestations of p55TNFRf/f (n= 7) and p55TNFRMs-KO mice (n= 8) subjected to CAIA (total 3
experiments, n= 20 mice per genotype). Arthritis was induced in male mice by i.v. injection of 4mg collagen II antibody cocktail (Ab) on Day 0 followed by
75 μg LPS i.p. 3 days later. Scale bar: 1 mm. Data are presented as the mean± SEM. *P< 0.05, **P< 0.01 and ***P< 0.001 by two-tailed Student’s t-test
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inactivation of the p55TNFR in SFs was also inhibitory for the
development of arthritis in the TNFΔARE model (Supplementary
Figure 1B).
Previous studies on cytokine networks operating in the
collagen-antibody-induced arthritis (CAIA) demonstrated the
essential role of p55TNFR in the development of this induced
arthritic pathology30. To examine the cell-speciﬁc p55TNFR
requirements in the CAIA model, we generated p55TNFRMs-KO
mice that were injected with the anti-collagen antibody (Ab)
cocktail. None of the p55TNFRMs-KO mice developed any joint
inﬂammation either when monitored in the course of the disease
or in the histopathological analysis, in sharp contrast to
p55TNFR-sufﬁcient littermate controls, which exhibited the
reported clinical and histopathological manifestations at the peak
of disease (Fig. 1b and c). Thus p55TNFR-mediated signalling in
mesenchymal cells of the joints, namely SFs, is required for the
development of arthritic disease in three different TNF-
dependent models suggesting common and robust arthritogenic
mechanisms operating exclusively by p55TNFR on SFs.
Mesenchymal IKK2 mediates arthritic joint destruction. Hav-
ing established a mesenchymal-speciﬁc mechanism being
required for TNF/p55TNFR mediated arthritogenesis, we inves-
tigated the arthritogenic signals acting downstream of p55TNFR
in this cell type. NFκB is readily reported in mediating TNF
signals in inﬂammatory settings7, so we targeted IKK231 (encoded
by the Ikbkb gene and from now on referred as Ikk2) in a
mesenchymal-speciﬁc manner. We generated Ikk2Ms-KO animals,
which either were crossbred into hTNFtg background or sub-
jected to CAIA. Interestingly, the clinical manifestations in both
cases were ameliorated (Supplementary Figure 2A and B).
Notably, the hTNFtg Ikk2Ms-KO animals manifested swelled ankle
joints, clinically apparent as early as 3 weeks and throughout the
course of disease (Supplementary Figure 2A) albeit with unaf-
fected grip strength. Detailed histopathological analysis revealed
the absence of signiﬁcant cartilage degradation and bone erosions
in the joints of hTNFtg Ikk2Ms-KO mice in sharp contrast to the
respective ﬁndings in their littermate hTNFtg IKK2-sufﬁcient
mice, even at the advanced stage of the hTNFtg arthritic disease
(Fig. 2a). Interestingly, synovitis in the hTNFtg Ikk2Ms-KO mice
was preserved throughout the course of analysis. Similar results
were also observed in Ikk2Ms-KO animals subjected to CAIA.
However, in the collagen-Ab-treated Ikk2Ms-KO mice synovitis
appeared milder (Fig. 2b). These results show that, in TNF-
dependent models of arthritis, the absence of mesenchymal-
speciﬁc IKK2 is not sufﬁcient to fully attenuate the inﬂammatory
process, while its presence is required to promote the invasive and
tissue-destructive properties of arthritogenic SFs.
IKK2 deﬁciency leads to synovial death in vivo and ex vivo. To
dissect the mechanisms of mesenchymal-speciﬁc IKK2 involve-
ment in the development of arthritis in vivo, we ﬁrst sought to
examine death events in the joint of Ikk2Ms-KO mice. We
hypothesized that IKK2 deﬁciency may render Ikk2-null SFs
sensitive to death as previously described for other cell types32–34,
mainly due to TNF/p55TNFR signals. While the hTNFtg and
Ikk2f/f mice lacked any terminal deoxinucleotidyl transferase-
mediated dUTP-ﬂuorescein nick end labelling (TUNEL)-positive
cells in the joint area, detection of some cleaved-caspase-3-
positive (CC3+) cells, mainly in articular cartilage, was evident in
hTNFtg mice. The Ikk2Ms-KO mice in the arthritic models and,
interestingly, also in non-arthritic conditions exhibited a readily
detectable signal of TUNEL-positive cells in the all compartments
of the synovium (Fig. 3a, b). CC3+ cells were hardly detectable in
naive IKK2-sufﬁcient mice; however, in CAIA-subjected mice
groups of CC3+ cells were evident in areas of necrotic tissue close
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Fig. 2 Mesenchymal IKK2-dependent signals promote arthritic manifestations in TNF-mediated arthritis. a Representative histological images of H&E,
Toluidine Blue (TB) and Tartrate-Resistance Acid Phosphatase (TRAP) stained ankle joint sections and histological score of synovial hyperplasia, cartilage
destruction and bone erosion of hTNFtg Ikk2f/f and hTNFtg Ikk2Ms-KO mice (n= 10; age: 11 weeks). b Representative histological images of H&E-, TB- and
TRAP-stained ankle joint sections and histological score of synovial hyperplasia, cartilage destruction and bone erosion of Ikk2f/f (n= 7) and Ikk2Ms-KO mice
(n= 8) subjected to CAIA at the peak of disease (Day 8). (3 experiments, n= 20–22 mice per genotype). Scale bar: 100 and 50 μm. Data are presented as
the mean± SEM. **P< 0.01 and ***P< 0.001, by two-tailed Student’s t-test
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-02935-4 ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:618 |DOI: 10.1038/s41467-018-02935-4 |www.nature.com/naturecommunications 3
48
63
48
48
28
35
Ikk2 f/f hTNFtg Ikk2 f/f WT MEFs
N
ai
ve
hT
N
Ft
g
hTNFtg
CA
IA
CAIA
Ikk2f/f Ikk2Ms-KOa
c
TU
NE
L+
 c
el
ls
(%
 pe
r s
yn
ov
ial
 ar
ea
 m
m2
)
ed
b
***
***
******
DMSO DMSO DMSOML120B ML120B ML120B
TNF (ng/ml)
TNF (ng/ml)
TNF (ng/ml)
Su
rv
iva
l (%
)
Su
rv
iva
l (%
)
Su
rv
iva
l (%
)
Ikk2 f/f
Ikk2 f/f Ikk2
/
Ikk2 /
0 5 15 30 60 0 5 15 30 60Min
Il1TNF
10
8
6
4
2
0
150
125
100
75
50
25
0
150
125
100
75
50
25
0
150
125
100
75
50
25
0
2.0
1.5
1.0
0.5
0.0
Minutes upon
activation
0 15 30 45 60
Minutes upon
stimulation
0 15 30 45 60
150
125
100
75
50
25
0 0
0.
1
0.
5
2.
5 10 50 0 0.
1
0.
5
2.
5 10 500 10 20 50 10
0
25
0
0
0.
1
0.
5
2.
5 10 500 10 20 50 10
0
25
00
0.
1
0.
5
2.
5 10 50
150
125
100
75
50
25
0
150
125
100
75
50
25
0
150
125
100
75
50
25
0
150
125
100
75
50
25
0
150
125
100
75
50
25
0
150
15 *** * *
**
10
5
0
Ik
k2
f/f
Ik
k2
M
s-
KO
Ik
k2
f/f
Ik
k2
M
s-
KO
Ik
k2
f/f
Ik
k2
M
s-
KO
100
50
0
R
el
at
iv
e 
ik
k2
 e
xp
re
ss
io
n 
(%
)
(co
mp
are
d t
o i
kk
2f/
f  le
ve
ls
)
0 50 0 0.1 0.5 2.5 10 50 0 50 0 0.1 0.5 2.5 10 50 0 50 0 0.1 0.5 1 2.5 10 50
100
75
63
48
Ikk2 f/f Ikk2 f/fIkk2 / Ikk2 /
hTNFtg
IKK2
Tubulin
Ikk2 f/f Ikk2 /
Ikk
2
f/f
Ikk
2
f/f
Ikk
2
f/f
Ikk
2
f/f
Ikk
2
/

Ikk
2
/

Ikk
2
/

Ikk
2
/

Ikk
2
/

Ikk
2
/

Ik
B 
le
ve
ls
Ikk2f/f + TNF
Ikk2Δ/Δ + TNF
Ikk2f/f + IL-1β
Ikk2Δ/Δ + IL-1β
0 5 15 30 60 0 5 15 30 60
JNK1
IκB
Tubulin
pJNK1/2
hTNFtg Ikk2 f/f WT MEFs
TUNEL DAPI TUNEL DAPI
hTNFtg Ikk2 / Ikk2 –/– MEFs
CC3CC3
pJ
NK
2 
le
ve
ls
hTNFtg
*** ***
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to CC3-negative synovium (Fig. 3a, left panel). In the joints of
naive and CAIA-treated Ikk2Ms-KO mice CC3+ cells were evident
mainly in synovial lining. However, hTNFtg Ikk2Ms-KO mice were
characterized by the detection of few CC3+ cells mainly restricted
in sublining synovial area. The enrichment of TUNEL+ cells in
comparison to CC3+ cells in synovium areas, being mostly
obvious in hTNFtg Ikk2Ms-KO joints, indicates the ability of IKK2
to prevent more TNF-induced death entities than apoptosis.
Additionally, TUNEL positivity in the joint area of Ikk2Ms-KO
mice was lost in the absence of p55TNFR (Supplementary
Figure 3A), further indicating that p55TNFR/IKK2 signalling is
required for the survival of synovial cells in vivo.
To further elucidate the underlying mechanism leading to
death events in the joints of Ikk2Ms-KO mice, we established
primary cultures of SFs derived from all genotypes. Notably,
cultures enriched in IKK2-deﬁcient SFs from either naive or
arthritic Ikk2Ms-KO mice could not be achieved (Supplementary
Figure 3B) in sharp contrast to the reported high recombination
efﬁciency of Col6a1-Cre in combination with other conditional
alleles (e.g., Supplementary Figure 1A and ref. 6). To clarify the
potential efﬁcacy problems, we employed Col6a1-Cre Ikk2f/f in
combination with RosamT/mG mice35, in order to observe Cre-
mediated recombination events through the expression of GFP
reporter gene. The limited expansion of SFs derived from the
double mutant Col6a1-Cre Ikk2f/f RosamT/mG mice, as this was
detected by the ﬂow cytometric detection of Cre+ (GFP+) cells in
culture, compared to Col6a1-Cre RosamT/mG SFs suggested
defective survival and/or expansion of Ikk2-null SFs ex vivo
(Supplementary Figure 3C). Furthermore, SFs derived from
Col6a1-Cre Ikk2f/f p55TNFR−/− mice, which additionally lack the
p55TNFR signalling and previously shown devoid of TUNEL+
cells in the joint (Supplementary Figure 3A), exhibited successful
and functional deletion of IKK2 protein and expanded ex vivo
(Supplementary Figure 3B and D), indicating that p55TNFR-
mediated signals account for the survival deﬁcits of Ikk2-null SFs
in ex vivo cultures.
Owing to aforementioned limitations in ex vivo culturing, we
ﬁrst applied an IKK2 inhibitor (ML120B)19 in WT or hTNFtg SF
cultures and then subjected them to TNF-induced death assay
(Fig. 3c). In all the IKK2-inhibited cultures tested, even very low
TNF doses led to excessive death of SFs (Fig. 3c) being evident as
early as 4–5 h upon stimulation. Moreover, when the same
conditions (IKK2 inhibitor and TNF) were applied to other cell
types, such as mouse embryonic ﬁbroblasts (MEFs; Fig. 3c), none
of the cultures exhibited the respective hyper-sensitivity of IKK2-
inhibited SFs. We then sought to mimic in vivo conditions and
study the function of genetic deﬁciency of Ikk2 in ex vivo SF
cultures, a TAT-Cre peptide was applied to Ikk2f/f and hTNFtg
Ikk2f/f SF cultures. Both Ikk2-null cultures successfully developed
and grew ex vivo (Fig. 3d). The ex vivo generated Ikk2-null SFs
(from now on referred as Ikk2Δ/Δ) displayed altered TNF- and
interleukin (IL)-1-induced responses, as indicated by failure of
IkB degradation, whereas phosphorylation of c-Jun N-terminal
kinase1/2 (JNK1/2) was prolonged (Fig. 3d) in agreement with
published evidence36. When different quantities of TNF were
applied to Ikk2Δ/Δ cultures, we observed hyper-sensitization to
death responses similar to the IKK2-inhibited SF cultures
(Fig. 3e). Addition of cycloheximide (CHX) in the TNF-treated
cultures ampliﬁed TNF-induced death indicating the essential
role of de novo protein synthesis in survival (Supplementary
Figure 3E). The hTNFtg Ikk2Δ/Δ SF cultures were sensitive to TNF
as well (Fig. 3d), yet their sensitivity was lower compared to the
IKK2-inhibited hTNFtg SF cultures. Interestingly, inhibition of de
novo protein synthesis by CHX sensitized hTNFtg Ikk2Δ/Δ SFs to
death even in the absence of exogenous TNF signals (Supple-
mentary Figure 3E), indicating that a constant inﬂux of
antiapoptotic molecules, such as the CHX-targeted cFLIP(L)37, is
required for the prevention of death in hTNFtg Ikk2Δ/Δ SF
cultures. Collectively, our results show that IKK2 signals operat-
ing downstream of the p55TNFR in SFs, either acutely or
chronically experienced to TNF, are strongly required for their
survival in vivo and ex vivo.
Naive and hTNFtg Ikk2-null SFs respond differently to TNF.
We then investigated potential mechanisms that lead to the death
of Ikk2-deﬁcient SFs in vivo and ex vivo by examining pro-
liferation capacity and the expression of TNF/NFκB-induced
genes implicated in cell survival and activation. Synchronized,
TAT-Cre-treated SFs of Ikk2f/f and hTNFtg Ikk2f/f cultures
(Fig. 4a) were subjected to 3-[4,5-dimethylthiazol-2-yl]-2,5
diphenyl tetrazolium bromide (MTT) incorporation assay
revealed defects in overall survival activity of hTNFtg Ikk2Δ/Δ
compared to hTNFtg Ikk2f/f SF cultures (Fig. 4b). In protein
expression analysis level, we identiﬁed the NFκB-regulated vas-
cular cell adhesion molecule (Vcam)-1 and intercellular adhesion
molecule (Icam)-1 expression of hTNFtg Ikk2-null SFs being
signiﬁcantly downregulated compared to the Ikk2-null or
IKK2–sufﬁcient SFs, which exhibited similar levels of Vcam-1/
Icam-1 expression (Fig. 4b). Surprisingly, hTNF protein expres-
sion was almost three-fold upregulated in hTNFtg Ikk2-null cell
supernatants compared to respective control supernatants from
hTNFtg SF cultures (Fig. 4b). We also noticed that, upon TNF
stimulation, the caspase3/8-mediated PARP1 cleavage pathway
was successfully activated in Ikk2-null SFs, indicating the acti-
vation of the apoptotic pathway in the absence of NFκB signalling
and in sharp contrast to the respective responses of hTNFtg Ikk2-
null SFs (Fig. 4c, Supplementary Figure 4A). Consistent with the
effect of IKK2 deﬁciency in the activation of caspases upon TNF
stimulation, the antiapoptotic molecules cIAP-1, Xiap, and
cFLIP(L) as well as the antioxidant enzyme Sod2 failed to upre-
gulate their expression in Ikk2-null SFs, whereas this was not
evident in the case of hTNFtg Ikk2-null SFs (Fig. 4c, Supple-
mentary Figure 4A).
Quantitative PCR analysis revealed the defective RNA expres-
sion of NFκB-regulated molecules, such as IL6, RankL (encoded
by Tnfsf11 gene), Mmp-3, -13 and -14 in all Ikk2-null SF extracts;
however, the Timp1 expression remained unaltered (Fig. 4d). The
hTNFtg Ikk2-null SFs presented a partly attenuated phenotype
compared to hTNFtg IKK2-sufﬁcient SFs, characterized by
spontaneous cytokine and matrix metalloproteinase (MMP) gene
expression, which is merely changed upon further TNF stimula-
tion (Fig. 4d). Interestingly, naive Ikk2-null cells exposed to TNF
presented slightly upregulated the Il1b RNA expression; however,
the difference did not reach statistical signiﬁcance compared to
TNF-exposed IKK2-expressing SFs (Fig. 4d). Collectively, these
results indicate that, depending on the chronicity of TNF signals
imposed on SFs, proinﬂammatory and survival gene expression
responds differentially to the absence of IKK2 signals, with acute
TNF signals (such as transiently induced in CAIA conditions)
leading Ikk2-deﬁcient SFs mainly to changes in proinﬂammatory
gene expression and apoptotic activation, while in contrast,
chronic TNF-experienced Ikk2-null SFs (hTNFtg background)
exhibited less profound changes in pro-inﬂammatory activation
and no overt differences in antiapoptotic responses.
IKK2 abrogates TNF-induced Ripk1-dependent death in SFs.
To gain insight into the mechanisms that regulate the differential
apoptotic response of Ikk2-deﬁcient SFs and the sensitivity of the
hTNFtg Ikk2-deﬁcient SFs to a caspase3/8-independent death, we
subjected the Ikk2-null SF cultures to TNF treatment in the
presence of pan-caspase and/or Ripk1/Mlkl inhibitors (zVAD or
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Fig. 4 IKK2 deﬁciency differentially affects gene expression of naive and arthritic SFs. a Representative immunodetection of IKK2 levels in TAT-Cre treated
Ikk2f/f (Ikk2Δ/Δ) and TAT-Cre treated hTNFtg Ikk2f/f (hTNFtg Ikk2Δ/Δ) SFs compared to non-treated control cultures Ikk2f/f and hTNFtg Ikk2f/f, respectively
(upper panel). b Representative MTT incorporation assay in the indicated genotypes; hTNF quantitation in the supernatants of hTNFtg Ikk2Δ/Δ (grey
column) and control hTNFtg Ikk2f/f SF cultures (black column) (n= 7, 2 experiments); ﬂow cytometric detection of Vcam-1 and Icam-1 levels in cultured
hTNFtg Ikk2f/f (black), hTNFtg Ikk2Δ/Δ (grey) and control SFs (Ikk2f/f: dotted black and Ikk2Δ/Δ: dotted grey) (n= 4, 2 experiments). c Representative
immunodetection of Casp8 (C8), Cleaved Casp3 (CC3), Parp1, Sod2, Xiap, cIAP-1 and cFLIP(L) in cell extracts of Ikk2Δ/Δ, hTNFtg Ikk2Δ/Δ and control SF
cultures treated with TNF (20 ng/ml, 5 h) (n= 10). d Relative gene expression of the NFκB-regulated genes Il6, Mmp-3, -13, -14, Timp1, Il1b and Tnfsf11
(RankL) (normalized to b2m levels) in SFs of the indicated genotypes upon TNF (20 ng/ml, 5 h) (n= 3–8). e Survival rates of Ikk2Δ/Δ and hTNFtg Ikk2Δ/Δ
SFs treated with TNF, zVAD, Nec1s and GW806742X (GW) as indicated (n= 3). f Representative immunodetection of pMlkl, Mlkl, Ripk3, cFLIP(S) and
IKK2 levels in TNF-treated Ikk2Δ/Δ, hTNFtg Ikk2Δ/Δ and control SF cultures (TNF: 20 ng/ml, 5 h) (n= 8, 4 experiments). Data are presented as the mean±
SEM. *P< 0.05, **P< 0.01 and ***P< 0.001, by two-tailed Student’s t-test (b, d) or one-way ANOVA (e). Unprocessed original scans of blots are shown in
Supplementary Fig. 8
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Nec1s/GW806742X inhibitor38, respectively). Interestingly, TNF-
induced death was partially rescued in Ikk2-null SFs by either
treatment, indicating that besides the caspase-mediated death, a
caspase-independent and Ripk1/Mlkl-mediated death is also at
play. The hTNFtg Ikk2-null SFs, even in the absence of additional
TNF treatment, were extremely sensitive to caspase inhibition
that led to a high percentage of dead cells (Fig. 4e). This zVAD-
induced death was prevented by co-treatment with either Nec-1s
or Nec-1 (data not shown; similar effects to Nec1s) or
GW806742X inhibitor indicating a zVAD-induced, Ripk1/Mlkl-
dependent death taking place in hTNFtg Ikk2-null SFs (Fig. 4e).
To explore the displayed sensitivity of hTNFtg Ikk2-null SFs to
necroptotic-like events, we followed the Mlkl phosphorylation
upon TNF stimulation, a key event in necroptotic death. We
identiﬁed Mlkl phosphorylation in Ikk2-null SFs upon a 5 h TNF
stimulation (Fig. 4f) even in the presence of effective caspase
activation (Fig. 4c), and low but readily detectable and sponta-
neous Mlkl phosphorylation happening in the hTNFtg Ikk2Δ/Δ
SFs, which was further enhanced in the presence of TNF (Fig. 4f,
Supplementary Figure 4B). We also noticed the upregulation of
both Ripk3 and Mlkl levels in the hTNFtg Ikk2Δ/Δ cells, indicating
that these upregulations may account for the spontaneous Mlkl
phosphorylation events (Fig. 4f). Notably, the expression of FLIP
(s), a form of FLIP implicated in the predisposition of cells to
necroptosis through its regulatory function in the ripoptosome
complex39, was upregulated in the hTNFtg Ikk2Δ/Δ cultures
(Fig. 4f) further implicating a necroptotic pathway being active in
the hTNFtg Ikk2-null cells. Collectively, these data indicate an
unusual potential of TNF-stimulated Ikk2-deﬁcient SFs to pro-
gram their cell death through both caspase-dependent and
-independent pathways, with the balance tipping towards to
Ripk1-mediated caspase-independent death when these cells have
been chronically exposed to TNF signals.
Ripk3 ablation abrogates synovitis in hTNFtg Ikk2Ms-KO mice.
Following our ex vivo evidence on the susceptibility of hTNFtg
Ikk2-null SFs to different death events accompanied by an
upregulation of Ripk3 levels, we investigated whether the altered
gene expression and the death predisposition could account for
the persisting synovitis manifested in hTNFtg Ikk2Ms-KO mice.
Ripk3 acts downstream of Ripk1 in the TNF pathway, regulating
both cellular demise and gene expression (reviewed in ref. 40).
The absence of any effect of Ripk3 deﬁciency in the development
of arthritis in hTNFtg mice (Supplementary Figure 5A, B)
indicated that Ripk3-mediated signals are dispensable for the
arthritogenic behaviour of hTNFTg SFs in vivo. Interestingly
when we generated hTNFtg Ikk2Ms-KO mice crossbred into
Ripk3−/− background, we observed that mice did not develop any
sign of arthritic disease. Histological analysis of the ankle joints
supported the results of the clinical examination, revealing intact
joint architecture and absence of any signs of synovitis, cartilage
destruction and bone erosions compared to hTNFtg Ikk2Ms-KO
mice (Fig. 5a and Supplementary Figure 6A). Histomorphometric
analysis in the cancellous bone tissue of calcaneus, a bone pri-
marily affected in hTNFtg arthritis, conﬁrmed that several bone
indices were comparable to the non-arthritic littermate controls
(Supplementary Figure 6B).
To dissect the molecular aspects of the Ripk3 pathway in the
behaviour of Ikk2-null SFs, we generated Ikk2/Ripk3-null cultures
ex vivo from both naive and hTNFtg mice (Supplementary
Figure 6C). Ripk3 deﬁciency did not affect the elevated levels of
Vcam-1 and Icam-1 on the cell surface of hTNFtg SFs. Moreover,
it did not alter the already downregulated expression of these
proteins in hTNFtg Ikk2Δ/Δ Ripk3−/− SFs (Supplementary
Figure 6D) compared to hTNFtg Ikk2Δ/Δ SFs and in sharp
contrast to hTNFtg IKK2-sufﬁcient controls (Fig. 4b). Remark-
ably, even though the single Ripk3 deﬁciency did not alter the
hTNF expression levels of hTNFtg SFs, however, the high hTNF
levels detected in hTNFtg Ikk2Δ/Δ supernatants were normalized
in the concomitant absence of IKK2 and Ripk3, reaching the
respective levels of hTNFtg IKK2-sufﬁcient controls (Supplemen-
tary Figure 6E) indicating that, only in the absence of IKK2,
Ripk3-mediated signals regulate hTNF expression.
The SF cultures were also subjected to TNF/zVAD/Nec1
treatments. The hTNFtg Ikk2/Ripk3–null SFs were completely
protected by TNF- and zVAD-induced death conﬁrming ex vivo
that Ripk3-mediated signals are responsible for the cell death seen
in hTNFtg Ikk2Δ/Δ SFs (Fig. 5b). TNF treatment of control Ikk2Δ/
Δ Ripk3−/− SFs led to a similar pattern of death compared to
Ikk2Δ/Δ SFs (Figs. 5b and 3d, respectively). All TNF/zVAD-
treated Ikk2/Ripk3-null cultures tested retained their ability to
fully survive as the non-treated control in contrast to the partial
death provoked by activation of caspases in the TNF/Nec1-
treated Ikk2/Ripk3-null SFs (Fig. 5b), indicating that Ripk3
deﬁciency does not alter the apoptotic responses previously
observed in Ikk2-deﬁcient SFs. Consistent with the effects of
Ripk3 deﬁciency on the TNF-induced death assays, the Mlkl
phosphorylation was absent from any Ikk2/Ripk3-null culture
(Fig. 5c), whereas caspase-3/8 activation, as well as XIAP
expression followed the expected patterns caused by Ikk2
deﬁciency upon TNF stimulation (Fig. 5d). Interestingly, the
hTNFtg Ikk2Δ/Δ Ripk3−/− SFs presented a slight activation of
caspases; however, FLIP(S) expression remained elevated com-
pared to Ikk2Δ/Δ Ripk3−/− cells (Fig. 5d).
Collectively, these ﬁndings exclude a direct role of Ripk3
involvement in TNF-mediated arthritis. Moreover, our evidence
indicates that the inhibition of Ripk3 would act beneﬁcially only
in the absence of mesenchymal IKK2-mediated signals in chronic
arthritis. Mechanistically, the Ripk3 pathway conditionally
controls gene expression and/or the cell death decisions, which
were observed ex vivo in the hTNFtg Ikk2-deﬁcient SFs thus
suggesting that the persisting synovitis in hTNFtg Ikk2Ms-KO
animals could be provoked by a Ripk3-mediated inﬂammatory
process.
TNF induces RIPK1-mediated death in proteasome-inhibited
RA-SFs. Previous studies involving genetic or pharmacological
inhibition of IKK2 in human RA-SFs suggested a role of IKK2-
mediated signalling affecting mainly proinﬂammatory gene
expression in the absence of death responses19,22,23. These results
indicated that IKK2 is not a prominent NFκB inhibitor that
affects pro-survival signalling in RA-SFs. Here we examined the
expression levels of necroptosis related molecules RIPK3 and
MLKL. We noticed that both molecules are expressed in RA-SFs
and osteoarthritis (OA)-SFs with no signiﬁcant differences
between the two types (Supplementary Figure 7A, B). We then
sought to examine an experimental setting that affects survival of
human SFs by affecting NFκB responses. MG132 effectively
blocks the proteolytic activity of the 26S proteasome complex
thus affecting pathways including NFκB and inducing apoptotic
cell death41. Importantly, it was shown to affect survival of
human SFs too42. Thus, upon MG132/TNF treatments, both RA-
and OA-SFs from ﬁve patients were prone to death (Supple-
mentary Figure 7C). Individual treatments with either caspase
inhibitor or Nec1 marginally (but not statistically signiﬁcant)
rescued cells from death, abrogating any favouring for any of the
two death pathways in any cell type. In sharp contrast, the
combinational treatment with both inhibitors fully restored sur-
vival of TNF/MG132-treated SFs (Supplementary Figure 7C).
Interestingly, by looking at individual sample responses
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(Supplementary Figure 7D), we noticed that 2 out of 5 samples
(40%) from both OA and RA patients have been partially rescued
by each inhibitor treatment suggesting that the TNF/MG132-
mediated effects are not limited to a caspase-mediated death but
also includes another RIPK1-mediated cellular demise in the SFs
of some patients. We also conﬁrmed the RIPK1 speciﬁcity by
applying Nec1s inhibitor in responsive samples, which indeed
showed a similar pattern of responses (Supplementary Figure 7E).
These results indicate the involvement of differential death
responses in the absence of intact survival signalling in human
SFs as we noticed in murine Ikk2-null SFs.
Discussion
We have previously demonstrated the sufﬁciency of
TNF/p55TNFR-signalling in SFs for the orchestration of murine
TNF-dependent arthritis6; however, the requirement of this cell-
speciﬁc pathway for the development of disease has remained
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unclear. In this study, by employing the arthritic hTNFtg and
TNFΔARE models in combination with cell-speciﬁc inactivation of
the p55TNFR, we provide novel evidence for the indispensable
role of mesenchymal-speciﬁc TNF/p55TNFR signalling in the
pathogenesis of modelled TNF-mediated arthritis. Furthermore,
we demonstrate the key function of this pathway across models
by showing its requirement also in the CAIA model43,44. We have
thus unraveled a common cellular basis explaining TNF-mediated
inﬂammatory and destructive arthritis, independently of whether
stromal (as in hTNFtg)6, innate (as in TNFΔARE)6 or adaptive (as
in CAIA)43 stimuli are instigating pathology. These ﬁndings may
translate into respective TNF-driven mechanisms operating in
several subclasses of human arthritides and explain the com-
paratively broad success of anti-TNF therapies in RA patients.
In light of this evidence, we then examined the mesenchymal-
speciﬁc function of IKK2, a natural mediator of TNF/p55TNFR
signals. IKK2 deﬁciency in mice is lethal due to a massive
apoptotic response in the embryonic liver caused by defective
NFκB activation32–34. Cell-speciﬁc KO approaches revealed the
essential role of IKK2 in TNF- and TLR-mediated activation of
NFκB and its importance in regulating inﬂammatory and pro-
liferative as well as death responses (reviewed in ref. 45). Owing to
such pro-inﬂammatory and pro-survival functions, NFκB
appeared as an appealing pharmacological target. Indeed, several
IKK2 inhibitors have been developed; however, almost none
achieved the criteria to pass into clinical applications. This was
mainly due to the lack of speciﬁcity and multiple side effects that
were poorly reported in the preclinical studies most probably due
to the short term application of the protocols (reviewed in ref. 46).
Interestingly, longer IKK2 inhibition led to leukocyte death and
increased neutrophilia, rendering the mice severely immuno-
compromised47, susceptible to endotoxemia48 and autoimmune
diseases49, indicating that inactive IKK2 leads to miscellaneous
responses depending on the cell target. Our observations revealed
that targeted mesenchymal IKK2 deﬁciency did not lead to overt
phenotypes. By employing the hTNFtg model of chronic arthritis,
we observed that, regardless of the ameliorated arthritic pheno-
type and the preserved joint architecture, mice with joint
mesenchymal cells deﬁcient in IKK2 still developed a sustained
synovitis throughout the course of chronic disease, indicating that
IKK2 acts as a checkpoint regulator of the progression from
synovitis to pannus formation.
Mechanistic ex vivo studies on Ikk2-null SFs suggest that the
naive Ikk2-null SFs exhibit an inﬂammatory and antiapoptotic
transcriptional insufﬁciency caused by the defective NFκB and
caspase-3 activation in response to TNF, in line with previous
reports50. Surprisingly, the hTNFtg Ikk2-null SF population was
selectively expressing some inﬂammatory proﬁles despite their
chronic TNF exposure (Fig. 4b, d). However, their resistance to
activate caspase-3 ex vivo could be correlated with unaltered
antiapoptotic responses, such as IAPs (Fig. 4c), similar to what
has been reported for RA-SFs51.
Biochemical approaches employing Ikk2-null SFs revealed the
extreme sensitivity of cells to death in response to even minute
concentrations of TNF compared to the more resistant Ikk2-null
MEFs, suggesting that the threshold of responsiveness of SFs to
TNF may be much lower compared to other mesenchymal cell
types. The application of a pan-caspase inhibitor, a speciﬁc Ripk1
inhibitor and an Mlkl inhibitor in both naive and hTNFtg Ikk2-
deﬁcient SFs revealed that, besides the expected caspase-
dependent death (apoptosis), a caspase-independent, yet Ripk1/
Mlkl-dependent death is taking place in the absence of IKK2.
Even though the GW806742X inhibitor (targeting Mlkl) had been
recently reported to affect the human RIPK1/3 activity too52, the
TNF-induced phosphorylation of Mlkl in Ikk2-null SFs and the
spontaneous phospho-Mlkl expression in hTNFtg Ikk2Δ/Δ SFs
(chronically exposed to TNF) indicate a possible Mlkl involve-
ment in our experimental system. Moreover, we show that IKK2
regulates hTNF, Ripk3 and Mlkl protein expression under
chronic inﬂammatory conditions (hTNFtg Ikk2Δ/Δ SFs; Fig. 4b, f).
In turn, changes in the FLIPL/FLIPS ratio may prevent necrop-
totic events caused by the insufﬁcient caspase-8 release from
apoptosome, favouring necrosome rather than apoptosome
function as previously reported39,53,54. These ex vivo results are
well correlated with the in vivo detection of death events marked
by TUNEL reactivity in the joint mesenchyme in sharp contrast
to the control IKK2-sufﬁcient mice, which developed full-blown
arthritis. Further analysis employing cleaved caspase-3 detection
in vivo stratiﬁed the death events according to the genotype, the
chronicity of inﬂammatory conditions and, interestingly, the
anatomic location; even though TUNEL indiscriminately marked
the Ikk2-deﬁcient synovium area irrespectively of the naive or
arthritic conditions, CC3+ cells were mainly located in the lining
part in naive and CAIA-treated mice (acute arthritis). Notably,
the hTNFtg Ikk2-deﬁcient synovium is surprisingly less prone to
CC3-mediated apoptotic events marked with a few CC3+ cells,
located mainly in sublining area regardless of uniform staining of
TUNEL throughout the synovium. This and our ex vivo ﬁndings
suggest that either Mlkl phosphorylation and caspase activation is
happening within the same Ikk2-deﬁcient cell or that distinct cells
within the Ikk2-deﬁcient SF population die by different modes of
death. In this regard, it is possible that distinct SF types exist
within the synovium and differentially regulate local responses
that affect the physiology of the joints leading to pathologic
situations. Moreover, numerous reports have analysed the resis-
tance of arthritic SFs to apoptosis (reviewed in ref. 51) rendering
the re-activation of their death machinery as a potential ther-
apeutic approach. However, the segregation of programmed cell
death into apoptosis, necroptosis, pyroptosis, etc, depending on
the molecular players and the processes involved, has started
clarifying their functional signiﬁcance in physiology and disease.
The inﬂammatory nature of necroptotic death due to the release
of damage-associated molecular patterns compared to the
immunological quiescent apoptotic death40 may explain the
abrogation of the residual inﬂammation seen in the synovium in
the absence of both IKK2 and Ripk3 signalling in SFs, whereas
Ripk3 were dispensable for the development and progression of
the chronic TNF-mediated arthritis. Interestingly, this latter
ﬁnding contrasts the previously reported acceleration of resolu-
tion phase of arthritis caused by the Ripk3 deﬁciency in the KRN-
serum transfer arthritis model13. Of note, the KRN-serum
transfer model of arthritis is minimally TNF dependent and
more TLR4 and IL-1β dependent55, and the diminished
TLR4/TRIF/Ripk3-dependent IL-1β expression by macrophages,
and not macrophage necroptosis, could explain the observed
differences13. In our study, we clearly show that the mesenchymal
compartment of the hTNFtg joints, namely SFs, is the major
responder to TNF arthritogenic signals that could act indepen-
dently to induce synovitis even in defective IL-1 conditions56,57,
as this could happen, e.g., in a Ripk3-null background. Moreover,
IKK2/Ripk3 deﬁciency is rather relevant to the downregulation of
hTNF release by the double IKK2/Ripk3-deﬁcient hTNFtg SFs
compared to hTNFtg Ikk2-null SFs (Suppl. Figure 6E). The double
deﬁciency could be also associated with the loss of spontaneous
Mlkl phosphorylation and the diminished caspase-independent
death seen ex vivo as well as the neutralization of arthritis seen
in vivo.
Another possible explanation for the differential death sus-
ceptibility of Ikk2-deﬁcient SFs could be attributed to the phos-
phorylation state of Ripk1, as it was recently exhibited that the
hypophosphorylated Ripk1 caused by compound IKK1/2 deﬁ-
ciency is responsible for the detection of different types of cell
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death (caspase-3/8-mediated apoptosis or Ripk3-mediated
necroptosis) depending on the context and independently of
NFκB activation; however, single Ikk2 deﬁciency was not sufﬁ-
cient to provide the same result in that study58. Interestingly,
another recent report suggested non-necroptotic functions of
either Mlkl and/or Ripk3 in controlling, at least partially, lym-
phoid tissue homeostasis via production of chemokines and
cytokines under caspase-8 or FADD deﬁciency59. Whether Ripk3
could further regulate altered gene expression in the arthritic
Ikk2-null SFs, as it has been reported for other cell types deﬁcient
in IAPs13,60–63, and/or death is yet to be explored. Further studies
employing several mutant mice for the molecular players of
necroptotic and apoptotic pathway will shed light on the con-
tribution of death pathways under mesenchymal IKK2 deﬁciency
in TNF-mediated arthritis.
Interestingly, even though IKK2 inhibition in OA- or RA-SFs is
not sufﬁcient to induce similar effects19, MG132, a potent NFκB
modulator acting through proteosomal inhibition and suggested
for the treatment of arthritis reviewed in66, provoked both
RIPK1-mediated caspase-dependent and -independent death in
SFs from some patients, providing translational evidence to our
murine-based observations.
In conclusion, our study provides novel mechanistic insights
into the mesenchymal-speciﬁc role of the IKK2 and Ripk3 axes
during TNF-dependent arthritogenesis, offering ex vivo and
in vivo evidence on their complementary functions in regulating
differential modes of pro-inﬂammatory synovial cell activation
and death with signiﬁcant impact on the physiological outcome in
modelled arthritis. Moreover, the distinct property of Ikk2-null
SFs to switch from a caspase-dependent to a Ripk3-mediated
caspase-independent mode of death following chronic TNF sti-
mulation suggests that combination of mesenchymal IKK2 tar-
geting along with Ripk3 blockade may be considered as an
optimal therapeutic strategy for the treatment of chronic arthritis.
Methods
Mice and induction of arthritis. Human TNF transgenic (hTNFtg), TNFΔARE,
Col6a1-Cre6, p55TNFRf/f29, Ikk2f/f33, p55TNFR−/−65, RosamT/mG37 and Ripk3−/−66
mice have been previously described. Col6a1-Cre Ikk2f/f and Col6a1-Cre
p55TNFRf/f mice are referred to as Ikk2Ms-KO and p55TNFRMs-KO, respectively. All
mice were maintained on a C57BL/6J except from hTNFtg Ikk2Ms-KO and litter-
mate mice, which were maintained in a CBA;C57BL/6J genetic background. Mice
were maintained under speciﬁc pathogen-free conditions in conventional, tem-
perature-controlled, air-conditioned animal house facilities of BSRC Alexander
Fleming with 14–10 h light/dark cycle and received food and water ad libitum.
CAIA was induced with a cocktail of four monoclonal IgG Abs, speciﬁc for four
well-deﬁned major epitopes on triple helical Collagen II, the C1 (CIIC1 clone), J1
(M2139 clone), D3 (CIIC2 clone) and U1 epitopes (UL1 clone)67 (MD Biosciences;
ArthritoMabTM; #CIA-MAB-2C). Brieﬂy, arthritis was induced in 6–8-week-old
littermate male mice of the indicated genotypes by intravenous injection of
ArthritoMabTM (4 mg) on day 0. On day 3, mice also received an intrapritoneal
injection of 75 μg lipopolysaccharide diluted in 150 μl phosphate-buffered saline
(PBS; E. coli strain 0111B4; MD Biosciences; #CIA-MAB-2C).
Clinical assessment of arthritis. Arthritis in hTNFtg animals was evaluated in
ankle joints in a blinded manner using a semiquantitative arthritis score ranging
from 0 to 4: 0: no arthritis (normal appearance and grip strength); 1: mild arthritis
(joint swelling); 2: moderate joint swelling and digit deformation, reduced grip
strength; 3: severe joint swelling and digit deformation, impaired movement, no
grip strength; 4: severe joint swelling and digit deformation, impaired movement,
no grip strength and obvious weight loss cachexia.
CAIA clinical evaluation was performed as previously described68. Brieﬂy,
arthritis was evaluated in a blinded manner for each of hindpaw and forepaw,
according to the following scale: 0 for normal appearance, 1 for swelling and/or
redness in one joint, 2 for swelling and/or redness in more than one joint, 3 for
swelling and/or redness in the entire paw, and 4 for maximal swelling. The ﬁnal
score value is the sum of the scores obtained from the four limbs of each mouse.
Histology. Formalin-ﬁxed, EDTA-decalciﬁed, parafﬁn-embedded mouse tissue
specimens were sectioned and stained with haematoxylin and eosin (H&E),
Toluidine Blue or Tartrate-Resistance Acid Phosphatase (TRAP) Kit [Sigma-
Aldrich]. H&E-, TB- and TRAP-stained joint sections were semiquantitatively
blindly evaluated for the following parameters: synovial inﬂammation/hyperplasia
(scale of 0–5), cartilage erosion (scale of 0–5), and bone loss (scale of 0–5) based on
an adjusted, previously described method69 (Supplementary Table 1).
Immunohistochemistry and TUNEL. TUNEL was performed in tissue sections
according to manufacturer's instructions [DeadEnd Fluorometric Tunel system;
Promega: #G3250]. The slides were deparafﬁnized, rehydrated and permeabilized
with 20 μg/ml proteinase K for 25 min at room temperature. The TdT-mediated
labelling reaction was performed for 60 min at 37 °C using ﬂuorescent-labeled
nucleotides. DAPI [4,6-diamidino-2-phenylindole; Santa Cruz Biotechnology, Inc.]
was used to stain the nuclei. Quantitation of TUNEL+ cells were performed with
the ImageJ software.
Cleaved caspase-3 detection was performed according to Ab manufacturer's
instructions [Cell Signalling; #9661; 1:200]. Brieﬂy, the slides were deparafﬁnized
and rehydrated. Antigen unmasking was performed in 1× Citrate Buffer, 45 min, at
90 °C. Upon endogenous peroxidase quenching and blocking, the incubation with
the Ab was performed overnight, and visualization was performed using the ABC
and DAB Kit [Vector laboratories; #PK-6100 and #SK-4105, respectively].
Microcomputed tomography. Microcomputed tomography (mCT) of excised
joints was carried out by a SkyScan 1172 CT scanner (Bruker, Aartselaar, Belgium)
following the general guidelines used for assessment of bone microarchitecture in
rodents using mCT70. Brieﬂy, scanning was conducted at 50 kV, 100 mA using a
0.5-mm aluminum ﬁlter, at a resolution of 6 mm/pixel. Reconstruction of sections
was achieved using the NRECON software (Bruker) with beam hardening cor-
rection set to 40%. The analysis was performed on a spherical volume of interest
(diameter 0.53 mm) within 62 slides of the trabecular region of calcaneus. Mor-
phometric quantiﬁcation of trabecular bone indices such as trabecular bone volume
fraction (BV/TV%), bone surface density (BS/TV%), trabecular number
(Tb. N; 1/mm) and trabecular separation (Tb. Sp; mm) were performed using the
CT analyser program (Bruker).
Cell culture. WT and Ikk2−/− MEFs were previously described71. Primary mouse
SFs were isolated from mice with the indicated genotypes and cultured for four
passages as previously described72. For Cre transduction experiments, 5 × 105 cells/
well (from passage 2) were plated on a 6-well plate, washed with PBS and incubated
for 16 h in 1:1 ﬁltered mixture of protein-free Dulbecco’s modiﬁed Eagle’s medium
(DMEM) and PBS containing 3 μM TAT-Cre (Millipore; #SRC508). After trans-
duction, cells were washed and cultured at least 2 days in normal DMEM/10%
foetal bovine serum, and transduced cultures were further expanded for 3 more
passages.
In experiments with the IKK2 inhibitor, pretreatment of cells with ML120B
(10μM)19 was performed for 3 h before addition of other reagents. zVAD [Bachem;
#N-1560], Nec-1 [Sigma-Aldrich; #N9037], Nec1s [BioVision; #2263] and
GW806742X [SYNkinase; #SYN-1215] were used in concentrations of 20, 30, 30
and 0.5 μM, respectively. TNF cytotoxicity assays were performed in 96-well plates,
terminated 18 h post TNF addition and evaluated upon crystal violet staining,
solubilization in 33% acetic acid solution and determination of optical density at
570 nm as a test ﬁlter and 630 nm as a reference ﬁlter.
For MTT assay, brieﬂy, 104 cells/well (5–7 wells/genotype), plated in 96-well
plates, were incubated for 24 h and then they were treated with MTT (Sigma-
Aldrich; #M5655; ﬁnal concentration 0.5 mg/ml/well). Plates were incubated for 5 h
in the CO2 incubator and the MTT-induced formed formazan is then solubilized in
DMSO, and the concentration was determined by optical density at 540 nm.
Flow cytometric analysis. Flow cytometric analysis was performed in cells stained
with the following Abs: CD90.2 [BioLegend; #105316; 1:300], VCAM-1 [BioLe-
gend; #105712; 1:400], CD45 [BioLegend; #103116; 1:400], ICAM-1 [BD Bios-
ciences; #553253; 1: 400], and CD11b [BD Biosciences; #557397; 1:400] using the
FlowJo analysis software.
Patients and isolation of human SFs. Synovial tissues were obtained from
patients diagnosed with OA or RA undergoing joint replacement surgery at the
Schulthess Clinic Zurich. RA patients fulﬁlled the American Rheumatism Asso-
ciation 1987 revised criteria for the classiﬁcation of RA. Patient’s characteristics are
summarized in Supplementary Table 2.
SFs were isolated by digestion with dispase (37 °C, 1 h) and cultured in
supplemented DMEM. All reagents were purchased from Life Technologies.
Cytotoxicity assay in human SFs. SFs were seeded at a density of 1.5 × 104 in 96-
well plates. After 24 h, cells were treated for 24 h with 10 ng/ml recombinant
human TNF-alpha [R&D systems; #210-TA], 50 µM InSolution™ MG-132
[Merck; #474791], 20 µM zVAD, 30 µM Nec-1 and/or 30 µM Nec-1s in duplicates.
The evaluation of viability was performed as described for murine SFs.
Immunoblotting. Samples were collected in RIPA buffer, containing 1% Triton X-
100, 0.1% sodium dodecyl sulfate (SDS), 150 mM NaCl, 10 mM Tris HCl, pH 7.4, 1
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mM EDTA, protease inhibitors [Roche] and phosphatase inhibitors [Sigma-
Aldrich], separated by SDS/polyacrylamide gel electrophoresis (8–12.5%), trans-
ferred to nitrocellulose membranes (Millipore) and probed with the following Abs:
IKK2 (#8943 or 2684; 1:1000), pJNK1/2 (#4668; 1:1000), cleaved caspase-3 (CC3;
#9661; 1:1000), PARP-1 (#9532; 1:1000), SOD2 (#13194; 1:1000), FLIP (#3210;
1:1000), XIAP (#2042; 1:1000) [Cell Signaling]; ikB (#sc-371; 1:1000), tubulin (#sc-
9104; 1:2000), actin (#sc-1615; 1:2000) [Santa Cruz Biotechnology, Inc.]; XIAP
(#ADI-AAM-050-E; 1:500), cIAP1 (#ALX-803–335-C100; 1:500), Ripk3 (#ADI-
905-242-100; 1:1000) [ENZO]; Mlkl [Millipore; #MABC604; 1:1000]; and pMlkl
[Abcam; #ab196436; 1:2000]. Relative quantitation of blots was performed either
with the ImageLab (BioRad) or Gene Sys (SYNGENE) software.
For human samples, probing were performed with the following Abs: tubulin
(Abcam; #ab21057; 1:2000), MLKL (Millipore; #MABC604; 1:1000), and RIP3
(Santa Cruz Biotechnology, Inc.; sc-374639; 1:1000). Relative quantitation has been
performed with the ImageJ software.
Statistical analysis. Data are presented as mean± SE. Student’s t-test (parametric,
unpaired, two-sided) was used for evaluation of statistical signiﬁcance (SigmaPlot
11 and GraphPad 6 software). P-values < 0.05 were considered signiﬁcant.
Study approval. Experiments with mice were performed in the conventional unit
of the animal facilities in Biomedical Sciences Research Center (BSRC) “Alexander
Fleming” under speciﬁc pathogen–free conditions, in accordance with the guidance
of the Institutional Animal Care and Use Committee of BSRC “Alexander Fleming”
and in conjunction with the Veterinary Service Management of the Hellenic
Republic Prefecture of Attika/Greece. Experiments were monitored and reviewed
throughout its duration by the respective Animal Welfare Body for compliance
with the permission granted. Experiments with human SFs were approved by the
Swiss Ethical Commission and patients signed an informed consent form.
Data availability. The data that support the ﬁndings of this study are available
from the corresponding authors upon reasonable request.
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